trial · primary record
Gardasil 9
Idiopathic CD4 T Cell Lymphocytopenia
| Phase | Phase 2 |
|---|---|
| Status | ACTIVE |
| Sponsor | Unknown |
| Enrolment | 54 |
| Primary completion | 2026-12-31 |
| Primary endpoint | Proportion of patients with ICL who become seropositive to at least 1 homologous HPV vaccine genotype at 1 month after completion of the vaccination schedule. |
| Registry ID | NCT03519464 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-29T14:33:13.061Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT03519464
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.